Management of Lobular Neoplasia Diagnosed by Core Biopsy.


Journal

The breast journal
ISSN: 1524-4741
Titre abrégé: Breast J
Pays: United States
ID NLM: 9505539

Informations de publication

Date de publication:
2023
Historique:
received: 04 11 2022
revised: 05 03 2023
accepted: 08 04 2023
medline: 1 5 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS can be further subdivided into three subtypes: classic LCIS, pleomorphic LCIS, and LCIS with necrosis (florid type). Because classic LCIS is now considered as a benign etiology, current guidelines recommend close follow-up with imaging versus surgical excision. The goal of our study was to determine if the diagnosis of classic LN on core needle biopsy (CNB) merits surgical excision. This is a retrospective, observational study conducted at Mount Auburn Hospital, Cambridge, MA, from May 17, 2017, through June 30, 2020. We reviewed the data of breast biopsies conducted at our hospital over this period and included patients who were diagnosed with classic LN (LCIS and/or ALH) and excluded patients having any other atypical lesions on CNB. All known cancer patients were excluded. Of the 2707 CNBs performed during the study period, we identified 68 women who were diagnosed with ALH or LCIS on CNB. CNB was performed for an abnormal mammogram in the majority of patients (60; 88%) while 7(10.3%) had an abnormal breast magnetic resonance imaging study (MRI), and 1 had an abnormal ultrasound (US). A total of 58 patients (85%) underwent excisional biopsy, of which 3 (5.2%) showed malignancy, including 2 cases of DCIS and 1 invasive carcinoma. In addition, there was 1 case (1.7%) with pleomorphic LCIS and 11 cases with ADH (15.5%). The management of LN found on core biopsy is evolving, with some advocating surgical excision and others recommending observation. Our data show a change in diagnosis with excisional biopsy in 13 (22.4%) of patients with 2 cases of DCIS, 1 invasive carcinoma, 1 pleomorphic LCIS, and 9 cases of ADH, diagnosed on excisional biopsy. While ALH and classic LCIS are considered benign, the choice of ongoing surveillance versus excisional biopsy should be made with shared decision making with the patient, with consideration of personal and family history, as well as patient preferences.

Identifiants

pubmed: 37114120
doi: 10.1155/2023/8185446
pmc: PMC10129432
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

8185446

Informations de copyright

Copyright © 2023 Chinmay Jani et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Diagn Interv Imaging. 2017 Mar;98(3):179-190
pubmed: 28131457
Am J Pathol. 1941 Jul;17(4):491-496.3
pubmed: 19970575
Eur J Breast Health. 2018 Apr 01;14(2):64-71
pubmed: 29774312
Ann Diagn Pathol. 2020 Apr;45:151481
pubmed: 32120324
Mod Pathol. 2016 Dec;29(12):1471-1484
pubmed: 27538687
Breast J. 2020 Dec;26(12):2350-2356
pubmed: 33047861
Eur J Surg Oncol. 2014 Feb;40(2):168-75
pubmed: 24246610
Hum Pathol. 1991 Dec;22(12):1232-9
pubmed: 1748429
Mod Pathol. 2022 Nov;35(11):1500-1508
pubmed: 35654997
Ann Surg Oncol. 2019 Jan;26(1):55-61
pubmed: 30362065
Mod Pathol. 1998 Sep;11(9):814-22
pubmed: 9758360
Health Technol Assess. 2020 Oct;24(55):1-24
pubmed: 33141657
J Surg Res. 2007 Oct;142(2):275-80
pubmed: 17662303
Clinicoecon Outcomes Res. 2018 Mar 26;10:157-167
pubmed: 29618934
Radiographics. 2007 Jan-Feb;27(1):79-94
pubmed: 17235000
Ann Surg Oncol. 2022 Mar;29(3):1660-1667
pubmed: 34554341
World J Surg Oncol. 2021 Mar 18;19(1):80
pubmed: 33736652
Ann Surg Oncol. 2012 Mar;19(3):914-21
pubmed: 21861212
Arch Med Sci. 2017 Apr 1;13(3):617-623
pubmed: 28507578
Ann Oncol. 2019 Aug 1;30(8):1194-1220
pubmed: 31161190
Mod Pathol. 2020 Jul;33(7):1287-1297
pubmed: 31932682

Auteurs

Chinmay Jani (C)

Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.

Margaret Lotz (M)

Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Division of Hematology-Oncology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.

Sarah Keates (S)

Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Division of Hematology-Oncology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.

Yasha Gupta (Y)

Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Department of Radiology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.

Alexander Walker (A)

Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.

Omar Al Omari (O)

Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.

Arshi Parvez (A)

Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.

Dipesh Patel (D)

Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Department of Radiology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.

Maria Gnata (M)

Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.

John Perry (J)

Department of Pathology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.

Leila Khorashadi (L)

Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Department of Radiology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.

Lisa Weissmann (L)

Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Division of Hematology-Oncology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.

Susan E Pories (SE)

Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH